University of Münster
CRIS@UM
DE | EN

Annika Adick

No current affiliations available for this person. The person is no longer active at the university.

Publications

Development of a screening platform for the formulation of poorly water-soluble drugs as albumin-stabilized nanosuspensions using nabTM technology
Adick, A.; Hoheisel, W.; Schneid, S.; Hester, S.; Langer, K. (2024)
In: International Journal of Pharmaceutics, 662.
Research article (journal)
A FRET-based assay for the identification of PCNA inhibitors
Hardebeck, S.; Schreiber, S.; Adick, A.; Langer, K.; Jose, J.  (2023)
In: International Journal of Molecular Sciences, 24.
Research article (journal)
Challenges of nanoparticle albumin bound (nab™) technology: Comparative study of Abraxane® with a newly developed albumin-stabilized itraconazole nanosuspension
Adick, A.; Hoheisel, W.; Schneid, S.; Mulac, D.; Azhdari, S.; Langer, K. (2023)
In: European journal of pharmaceutics and biopharmaceutics, 193.
Research article (journal)
Triglyceride-filled albumin-based nanocapsules: A promising new system to avoid discarding poorly water-soluble drug candidates
Hester, S.; Ferenz, K.B.; Adick, A.; Kakalias, C.; Mulac, D.; Azhdari, S.; Langer, K. (2023)
In: International Journal of Pharmaceutics, 646.
Research article (journal)
The mystery of nabTM technology: A transfer study.
Adick, A.; Hoheisel, W.; Schneid, S.; Langer, K. (2023)
In: 4th European Conference on Pharmaceutics, Marseille, France. 
Abstract in digital collection (conference)
Show all publications

Projects

Stabilisierung von nanopartikulären pharmazeutischen Wirkstoffen durch humanes Serumalbumin (HSA)
Duration: 02/06/2020 - 31/12/2023
Funded by: INVITE GmbH
Type of project: Individual project

Doctorates

HSA-stabilisierte Nanopartikel für intravenöse Anwendungen.
Candidate: Adick, Annika | Supervisors: Langer, Prof. Dr. Klaus | Reviewers: Lehr, M.
Period of time: 01/06/2020 - 31/12/2023
Doctoral examination procedure finished at: Doctoral examination procedure at University of Münster